Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated from...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uptake and associated factors of breast cancer screening using mammography and ultrasound in China: A multicenter population-based study.

Chinese medical journal·2026
Same author

Transcriptomic Analysis Based on RNA-Seq Technology Reveals the Molecular Mechanisms of Sunflower (<i>Helianthus annuus</i> L.) Response to Salt Stress.

Genes·2026
Same author

Associations of indoor bacterial, metabolomic, and other chemical exposures with allergic rhinitis in school-aged children.

BMC microbiology·2026
Same author

Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation study.

Cancer letters·2026
Same author

Safety assessment of autologous ovarian tissue cryopreservation and transplantation in cancer patients: an updated review.

Journal of ovarian research·2026
Same author

Pore Structure Engineering Enables Synergistic Interfacial-Bulk Kinetics in Hard Carbon for High-Rate Sodium-Ion Batteries.

ACS applied materials & interfaces·2026
Same journal

[Advances in research on neuroelectrophysiological characteristics of post-stroke cognitive impairment based on quantitative electroencephalography and acupuncture interventions].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same journal

[Mechanisms and applications of magnesium ion-regulated stem cell functions in promoting tendon-bone interface healing].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same journal

[Applications and challenges of ultra-high molecular weight polyethylene fibers in minimally invasive medical devices].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same journal

[Research on auditory neurofeedback technology and its multi-disciplinary applications].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same journal

[Application and perspective of novel auditory intervention paradigms based on verbal and nonverbal stimuli for severe traumatic brain injury].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same journal

[Research progress on the neuromodulation targets in stroke rehabilitation].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function
10:21

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function

Published on: August 8, 2019

[Research progress in estimating parameters of blood substitute function].

Jiaxin Xie1, Xiang Wang

  • 1College of Bioengineering, Chongqing University, Chongqing 400030, China.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi
|July 29, 2009
PubMed
Summary
This summary is machine-generated.

Developing effective blood substitutes is crucial due to blood shortages and virus risks. This review focuses on evaluating blood substitute properties, safety, and preservation, referencing global advancements.

More Related Videos

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Related Experiment Videos

Last Updated: Jun 21, 2026

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function
10:21

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function

Published on: August 8, 2019

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Materials Science

Background:

  • * Global blood shortages and risks of viral transmission necessitate the development of safe and effective blood substitutes.
  • * Current research focuses on modified hemoglobin, perfluorocarbons, and hemoglobin-vesicles (HbVs) for blood replacement therapies.
  • * Existing blood substitutes face challenges in comprehensive functional evaluation.

Purpose of the Study:

  • * To critically review and establish a comprehensive evaluation system for blood substitutes.
  • * To discuss key parameters for assessing blood substitute efficacy and safety.
  • * To present the latest global advancements in blood substitute research and development.

Main Methods:

  • * Literature review of international and domestic studies on blood substitute evaluation.
  • * Analysis of physical and chemical properties relevant to blood substitute function.
  • * Assessment of safety, availability, and preservation conditions for blood substitutes.

Main Results:

  • * Identified critical evaluation parameters including oxygen-carrying capacity, viscosity, and biocompatibility.
  • * Highlighted the importance of rigorous safety and toxicological assessments.
  • * Discussed optimal preservation techniques to maintain blood substitute stability and efficacy.

Conclusions:

  • * A standardized evaluation system is essential for the successful clinical application of blood substitutes.
  • * Further research is needed to fully characterize the long-term safety and efficacy of emerging blood substitute technologies.
  • * Optimizing physical, chemical, and preservation properties will accelerate the development of viable blood alternatives.